国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Escherichia coli O127:H6 Manganese transport protein MntH (mntH), partial CSB-YP487280EOB
CSB-EP487280EOB
CSB-BP487280EOB
CSB-MP487280EOB
CSB-EP487280EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O127:H6 Phosphoribosylformylglycinamidine cyclo-ligase (purM) CSB-YP487281EOB
CSB-EP487281EOB
CSB-BP487281EOB
CSB-MP487281EOB
CSB-EP487281EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O127:H6 Ribosomal RNA large subunit methyltransferase N (rlmN) CSB-YP487282EOB
CSB-EP487282EOB
CSB-BP487282EOB
CSB-MP487282EOB
CSB-EP487282EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O127:H6 Holo-[acyl-carrier-protein] synthase (acpS) CSB-YP487283EOB
CSB-EP487283EOB
CSB-BP487283EOB
CSB-MP487283EOB
CSB-EP487283EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O127:H6 Probable inorganic polyphosphate/ATP-NAD kinase (ppnK) CSB-YP487284EOB
CSB-EP487284EOB
CSB-BP487284EOB
CSB-MP487284EOB
CSB-EP487284EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O127:H6 Regulatory protein recX (recX) CSB-YP487285EOB
CSB-EP487285EOB
CSB-BP487285EOB
CSB-MP487285EOB
CSB-EP487285EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O127:H6 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (ispD) CSB-YP487286EOB
CSB-EP487286EOB
CSB-BP487286EOB
CSB-MP487286EOB
CSB-EP487286EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O127:H6 Enolase (eno) CSB-YP487287EOB
CSB-EP487287EOB
CSB-BP487287EOB
CSB-MP487287EOB
CSB-EP487287EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O127:H6 L-fucose mutarotase (fucU) CSB-YP487288EOB
CSB-EP487288EOB
CSB-BP487288EOB
CSB-MP487288EOB
CSB-EP487288EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O127:H6 D-phenylhydantoinase (hyuA) CSB-YP487289EOB
CSB-EP487289EOB
CSB-BP487289EOB
CSB-MP487289EOB
CSB-EP487289EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O127:H6 Chromosome initiation inhibitor (iciA) CSB-YP487290EOB
CSB-EP487290EOB
CSB-BP487290EOB
CSB-MP487290EOB
CSB-EP487290EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O127:H6 Thr operon leader peptide (thrL) CSB-YP487291EOB
CSB-EP487291EOB
CSB-BP487291EOB
CSB-MP487291EOB
CSB-EP487291EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O127:H6 Crotonobetainyl-CoA dehydrogenase (caiA) CSB-YP487292EOB
CSB-EP487292EOB
CSB-BP487292EOB
CSB-MP487292EOB
CSB-EP487292EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O127:H6 Protein ApaG (apaG) CSB-YP487293EOB
CSB-EP487293EOB
CSB-BP487293EOB
CSB-MP487293EOB
CSB-EP487293EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O127:H6 3-isopropylmalate dehydratase large subunit (leuC) CSB-YP487294EOB
CSB-EP487294EOB
CSB-BP487294EOB
CSB-MP487294EOB
CSB-EP487294EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O127:H6 UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC) CSB-YP487295EOB
CSB-EP487295EOB
CSB-BP487295EOB
CSB-MP487295EOB
CSB-EP487295EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O127:H6 H (+)/Cl (-) exchange transporter ClcA, partial CSB-YP487296EOB
CSB-EP487296EOB
CSB-BP487296EOB
CSB-MP487296EOB
CSB-EP487296EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O127:H6 30S ribosomal protein S2 (rpsB) CSB-YP487297EOB
CSB-EP487297EOB
CSB-BP487297EOB
CSB-MP487297EOB
CSB-EP487297EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O127:H6 Zinc transporter ZupT (zupT) CSB-YP487298EOB
CSB-EP487298EOB
CSB-BP487298EOB
CSB-MP487298EOB
CSB-EP487298EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O127:H6 Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP487299EOB
CSB-EP487299EOB
CSB-BP487299EOB
CSB-MP487299EOB
CSB-EP487299EOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>